Text
Kajian Epidemiologis Penyakit Paru Obstruktif Kronik (PPOK)
Chronic Obstructive Pulmonary Disease (COPD) was unknown diseases. It predicted 14 million COPD’s patient in 1991 in USA,in the other hand it raised to 41.5% compare with in 1982.Mortality rate have raised up 32.9% from 1979 to 1991. World Health Organization (WHO) assumed that COPD was in fourth ranks of cause of death in the world, would have 2.75 million mortality or equivalence with 4.8%. Otherwise WHO predicted 80 million people had COPD that 3 million among of them would be death in 2005. The aim of this study to measure COPD prevalenced, degree of severity, COPD types, risk factors, morbidity and mortality, impact of COPD and cost of health care in COPD. The data wasexplored of review COPD based on literature and journal that focused on type of COPD, risk factors, prevalence, morbidity and mortality, severe ranks, impact of COPD, medication and cost of PPOK medication.There were two types of COPD, i.e chronic bronchitis and emphysema. It was 6.3 % prevalence of COPD in South East Asian where maximum prevalences were in Vietnam (6.7%) and China (6.5%). The risk factors of COPD were smoking, indoor, outdoor and workplace pollution, genetic (ATT); repeated of infectious respiratory disease history.It was four indicators severe based on ATS (American Thoracic Society) standards. There were many impacts of COPD i.e; disability, decending of weight body, rising up of risk of cardiovascular disesase, osteoporosis and depression. It needed $ 18 billion to cover direct cost and $14.1 billion covered indirect cost, according to cope of COPDin Europe
No other version available